HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Pellegrini Selected Research

pycnogenols

9/2017Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings.
2/2014Pycnogenol® in postpartum symptomatic hemorrhoids.
9/2010Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study.
6/2010Kidney function in metabolic syndrome may be improved with Pycnogenol®.
9/2008Pycnogenol may alleviate adverse effects in oncologic treatment.
4/2008Treatment of osteoarthritis with Pycnogenol. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of signs, symptoms, physical performance and vascular aspects.
1/2008Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol.
10/2006Rapid relief of signs/symptoms in chronic venous microangiopathy with pycnogenol: a prospective, controlled study.
8/2006Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study.
7/2006Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Pellegrini Research Topics

Disease

14Edema (Dropsy)
09/2017 - 04/2003
8Venous Insufficiency
09/2010 - 03/2005
4Pain (Aches)
10/2016 - 04/2007
4Liver Failure
10/2015 - 02/2014
4Ulcer
09/2011 - 11/2005
4Hypertension (High Blood Pressure)
10/2006 - 08/2000
3Neoplasms (Cancer)
04/2016 - 01/2014
3Inflammation (Inflammations)
01/2016 - 01/2014
3Varicose Ulcer (Ulcer, Venous)
09/2011 - 11/2005
3Varicose Veins (Varicose Vein)
09/2011 - 04/2003
3Wounds and Injuries (Trauma)
09/2011 - 06/2010
3Osteoarthritis
06/2010 - 01/2008
3Thrombosis (Thrombus)
09/2008 - 04/2007
2Mesothelioma
04/2016 - 06/2015
2Alzheimer Disease (Alzheimer's Disease)
01/2016 - 11/2000
2Ischemia
09/2012 - 12/2010
2Intermittent Claudication
08/2012 - 08/2000
2Diabetic Angiopathies (Diabetic Angiopathy)
09/2011 - 08/2006
2Vascular Diseases (Vascular Disease)
10/2008 - 08/2000
2Venous Thrombosis (Deep-Vein Thrombosis)
09/2008 - 05/2004
2Infections
01/2008 - 04/2007
1Body Weight (Weight, Body)
10/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Chemical and Drug Induced Liver Injury
01/2020
1Autosomal Dominant Polycystic Kidney (ADPKD)
01/2020
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2017
1Hematoma
10/2016
1Carcinogenesis
04/2016
1Ulcerative Colitis
01/2016
1Malignant Mesothelioma
06/2015
1Fatigue
06/2015
1Liver Diseases (Liver Disease)
06/2015
1Fibrosis (Cirrhosis)
04/2015
1Atherosclerosis
04/2015
1Hepatitis
02/2014
1Hemorrhoids
02/2014
1Stroke (Strokes)
04/2013
1Ischemic Stroke
04/2013
1Hypoxia (Hypoxemia)
11/2012
1Pulmonary Embolism
09/2012
1Myotonic Dystrophy (Dystrophia Myotonica)
02/2012
1Lipodermatosclerosis
09/2011
1Parkinson Disease (Parkinson's Disease)
09/2011
1Cerebral Hemorrhage
12/2010

Drug/Important Bio-Agent (IBA)

13pycnogenolsIBA
09/2017 - 07/2005
5troxerutinIBA
06/2010 - 04/2003
4LecithinsIBA
01/2017 - 01/2014
4AntioxidantsIBA
10/2015 - 01/2008
45,11-methenyltetrahydrohomofolateIBA
10/2015 - 02/2014
3CurcuminIBA
01/2014 - 06/2010
2Oxygen (Dioxygen)IBA
10/2020 - 09/2011
2AnticoagulantsIBA
09/2012 - 04/2007
2Alprostadil (Muse)FDA LinkGeneric
08/2012 - 08/2000
2disilver oxideIBA
09/2011 - 06/2010
2Ointments (Pastes)IBA
09/2011 - 06/2010
2Peptide Hydrolases (Proteases)FDA Link
09/2011 - 07/2007
2Heparin (Liquaemin)FDA LinkGeneric
04/2007 - 04/2007
2Diosmin (Daflon)IBA
04/2006 - 03/2006
2HesperidinIBA
04/2006 - 03/2006
2Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2005 - 05/2004
1lixivaptanIBA
01/2020
1TolvaptanFDA Link
01/2020
1Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
01/2020
1Bile Acids and Salts (Bile Acids)IBA
01/2020
1AntistaxIBA
09/2017
1Pain-FreeIBA
10/2016
1AcidsIBA
10/2016
1Biomarkers (Surrogate Marker)IBA
10/2016
1AsbestosIBA
04/2016
1PlasticsIBA
01/2016
1LipidsIBA
01/2016
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2016
1Pharmaceutical PreparationsIBA
06/2015
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2015
1HMGB1 Protein (HMG1)IBA
06/2015
1RobuvitIBA
06/2015
1TECAIBA
04/2015
1Lisosan GIBA
04/2015
1Cisplatin (Platino)FDA LinkGeneric
04/2015
1BilirubinIBA
02/2014
1AlbuminsIBA
02/2014
1EnzymesIBA
02/2014
1Tissue Plasminogen Activator (Alteplase)FDA Link
04/2013
1StaurosporineIBA
11/2012
1Sirtuin 3IBA
11/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2012
1SugammadexIBA
02/2012
1Rocuronium (Zemuron)FDA LinkGeneric
02/2012
1Insulin (Novolin)FDA Link
09/2011
1Neuroprotective AgentsIBA
12/2010
1ErythropoietinFDA Link
12/2010

Therapy/Procedure

5Therapeutics
06/2015 - 06/2010
2Drug Therapy (Chemotherapy)
10/2015 - 01/2014
2Catheters
01/2014 - 04/2007
2Lasers (Laser)
05/2005 - 03/2005
1Artificial Respiration (Mechanical Ventilation)
10/2020
1Central Venous Catheters
01/2014
1Transplantation
04/2013
1Cell- and Tissue-Based Therapy (Cell Therapy)
04/2013
1Sclerotherapy
09/2011